High Cost of Pharmaceutical Medications Cause Poor Health Outcomes

HighCost of Pharmaceutical Medications Cause Poor Health Outcomes

HighCost of Pharmaceutical Medications Cause Poor Health Outcomes

Appropriatetreatment and concern for patients with the prescribed medicine callsfor the consistent application of drugs as prescribed by thephysician. According to Brennan,Kapczynski, Monahan and Rizvi (2016) mostof thepatients fail touse the drugs asprescribed. The high cost of medicines affects the quality of healthamong individuals and poor productivity among people in society. Thehigh cost of pharmaceutical medication in the United States has leftmany individuals being unable to follow the prescription of thedoctors in treating their diseases that have negative impacts ontheir health. High cost in America has made many citizens be in therealm of poor health. DiMasi (2014) argues that the United States hasthe highest price in pharmaceutical medication making it difficultfor most of the American tobeable to adhere to the prescriptions. The high cost of the drugs hasresulted from drug manufacturing companies that have been focusing onprofit maximization neglecting whether the patients can be in aposition to purchase the drugs or not. With an aim of curing thediseases, most individuals in the country have been substituting theprescribed drugs with cheaper ones that can pose a threat to theirlives. Research by Kantarjian,Steensma, Sanjuan, Elshaug and Light (2014),shows that individuals tend to comply with the prescriptions if theassociatetedcostis low. There is increased call to reduce the drug cost to improvethe health of people across the globe. The aim of the study is toevaluate and compare the relationship between the health condition ofan individual and cost of pharmaceutical medication

BusinessWire (2011)postulates that high cost of medicine discourages people fromconsuming the prescribed drugs made to treat the disease. The highcost mostly occurs because of the pharmaceutical companies beingconcerned about their profit and well-being. The government andmedical organization should intervene by coming up with new andadditional regulations and rules with the aim of reducing the cost ofthe prescription. In the country, the pharmaceutical companies havebeen interfering with the guidelines and policies establishedresulting in increased cost of their products. Reducing andimplementing new policies would help to improve the medicalconditions of individuals. With the present rules, regulations andpolicies, the pharmaceutical companies have remained in full controlof the industry dictating the price they require for their drugs.High cost of drugs in the country makes the clients to buy from othercountries and the drugs can be detrimental to their health causingpoor health performance.

Drugorganizations have been taking advantage of their influence inputting rules in place that favor them in making prices with anambition of making better profits making the medication to be high.The current regulations are playing a critical role in maintainingthe cost of pharmaceutical medication high therefore affecting thequality of health. Research by Brennane al., (2016)shows that failure of the patients to adhere to the prescription hasan adverse challenge to the community and society because it resultsin reduced health outcomes. The present rules and policies have madeit possible for the drug companies to dictate the prices they wouldcall for the drugs. The high cost of medications by the companiesreduces the affordability of the drugs by the clients especially thelower earners. DiMasi (2014) argues that in most developed countriesonly 50 percent of individuals suffering from chronic illnesses canfollow the prescriptions of the doctors. Patients use fewer drugs ormedicines especially because of high cost causing risks to the lifeand decreasing the quality of their health.

Accordingto Jain (2011),the high cost of drugs affects the performance of individuals in thesociety because of it causes poor health outcomes. The cost ofmedication should be set in a way that all the people can afford topurchase. Importation of medical facilities especially drugs haveproven to have detrimental impacts on the welfare of the people.Benkert,Krause, Wasem and Aidelsburger (2011)argue that to control the medical conditions of the people, themedical sector and the state government should intervene by imposingnew policies that would enable the drug companies to reduce theircost. Reduction of cost would help to ensure that the clients arereceiving high quality products that are not detrimental to theirwell-being. Research by Jain(2011)shows that, because of high cost of medication in most developednations, the burden of the cost is shifted to the patients who arerequired to pay more to acquire the right prescription. High cost hasdiscouraged individuals from visiting the medical organizationsincluding hospitals and purchase cheat drugs with an aim ofalleviating the problem. High cost has resulted to poor usage ofdrugs affecting health conditions of people across the states.

Thehigh cost of pharmaceutical medication has been high in the countrybecause the current policies have made it difficult for the UnitedStates to control the prices of drugs. Most of the other countrieshave been making progress in reducing their medication cost ascompared to America. On the other hand, the drug sector in thecountry has been able to influence the IRS that has made thecompanies make plentiful gains from their business. The companieshave been making significant profits through a high reduction oftheir tax and transfer of finances of the drug firms to offshoreaccounts where the level of tax is low. Patients suffer high cost ofpurchasing the drugs while the companies are making enormous progressin their profits. Inability to access the medicine because of thehigh prices poses significant risks to the health conditions of anindividual.

AStudy by Almashatand Wolfe (2012)shows that most people in America are purchasing their medical drugsthrough online source from other nations that are offering them at arelatively low price. Poor health of the patients arises whenconsidering the quality of the drugs purchased from other countries.The value of the drugs purchased online may not meet the requiredspecification affecting the medical conditions of the patients afterconsumption.Kantarjian etal., (2014)arguethat at least one patient from America purchases his or her drugonline from other countries because of high prices in the countriesof origin and the number is highly increasing. About 10 to 30 percentof medicines sold in other nations have a high likelihood of beingtampered compared to the drug manufactured from the developedcountries like America. By some of the drugs being counterfeit, thehealth conditions of the clients purchasing and using them is likelyto decrease and even cause additional health challenges.

Medicalconditions of an individual depend on the quality of services givenin the medical care organizations. High cost of drugs retards hehealth conditions especially for the poor people in a country. Jain(2011)postulates the establishment of rules ha ensure ha all hospitals havedrugs offered o he patients at low cost therefore boosting theirability by improving health conditions.

Althoughmost companies from other countries maybe selling the drugs at lowerprices, they may fail to reveal what they claim to be (Jain,2011).For example, most of the online pharmaceuticals are likely to asserttheir Canadian origin because of the high perception by the Americansthat the Canadian provides high-quality products mainly drugs. A testby scientists on the online drugs purchased shows the counterfeitnature of the drugs revealing the illegality of the online pharmaciesand therefore showing adverse impacts that of the drugs to theindividuals (Daniel,2016).The use of medicines from illegal online companies that may becounterfeit can cause additional health issues other thaneliminating.

Thehigh cost of pharmaceutical medication has made it difficult for mostindividuals especially the unemployed and the low-earning personsfrom consuming the quality drugs that matches their diseases.

TheCenters for Disease Control and Prevention (2014) calls forintroduction and implementation of new rules and policies that canreduce the medical cost and therefore, improving the medical orhealth conditions of people across the country. The relationship thatexists between the health status of an individual and the medicationshe or she is receiving is direct with high-quality medicationresulting in the improvement of the health conditions of a person andthe lower quality reducing the quality of health of a person. Turningto the work of Almashatand Wolfe (2012),one finds that in the United states, almost half of the population inAmerica suffer from at least one chronic disease and those who fallfull prescription from the physician have been showing positiveprogress in gaining their proper health as compared to patients whofail to follow the entire medication. Adhering to medical careconcerns reduces the spending on annual spending on healthcare andreducing emergencies. The high cost of drugs has adverse effects onthe quality of life. Introduction and review of the existing rulesand policies can help in improving the health conditions of people byensuring that the people can acquire the prescribed drugs at reducedcost, therefore, improving the sanitary conditions of the communityand society (Benkerte al.,&nbsp2011).


Thereexists a direct relationship between the cost of pharmaceuticalmedication and the health conditions of people in any given society.High cost of medicines encourages people to import drugs from othercountries that sell at a relatively lower price. New policies andregulations would give the state power to focus on the cost of theprescription to ensure that people get the drugs at lower prices thatcan help to improve their productivity and their health conditions.Changing the rules and policies would help to make sure that themedicine companies does not manipulate the prices of the drugs,therefore, maintaining the health conditions of individuals in thesociety. By controlling, the pharmaceutical companies would make iteasy for Americans to purchase drugs from the country. Reducing costof medication would help to improve the medical conditions of people.


Almashat,S.,&amp Wolfe, S. (2012). Pharmaceutical industry criminal and civilpenalties: An update. Retrieved fromhttp://www.citizen.org/documents/20731.pdf

Brennan,H., Kapczynski, A., Monahan, C.,&amp Rizvi, Z., (2016). Aprescription for excessive drug pricing: Leveraging government patentuse for health.TheYale Journal of Law and Technology,18,275-354.

Benkert,D, Krause, KH, Wasem, J, &amp Aidelsburger,&nbspP. (2011).Effectiveness of pharmaceutical therapy of ADHD(Attention-Deficit/Hyperactivity Disorder) in adults – healthtechnology assessment. (GMS Health Technology Assessment VOL:6 DOC13 /20100907.) German Medical Science GMS Publishing HouseDüsseldorf.

BusinessWire. (2011). The national association of boards of pharmacyandpfizerpartner to educate patients about the flood ofcounterfeit medicinesonline.Retrieved from http://www.businesswire.com/smp/spotfakemeds-pfizer/

Centerfor Disease Control and Prevention. (2014). Counterfeit Drugs.Retrieved fromhttp://www.cdc.gov/Features/CounterfeitDrugs/index.html

Daniel,H. (2016). Stemming the escalating cost of prescription drugs: Aposition paper of the American college of physicians. Annalsof Internal Medicine,165(1),50-52.

DiMasi,J. A. (2014). Cost of Developing a New Drug [PowerPoint slides].Retrieved fromhttp://csdd.tufts.edu/files/uploads/Tufts_CSDD_briefing_on_RD_cost_study_-_Nov_18,_2014..pdf

Herrick,D. (2016). A bogus solution for high drug costs. NationalCenter for Policy Analysis,194,1-4.

Jain,&nbspS.(2011). Understanding Physician-Pharmaceutical IndustryInteraction. Cambridge, GBR: Cambridge University Press.

Kantarjian,H., Steensma, D., Sanjuan, J. R., Elshaug, A., &ampLight, D. (2014).High cancer drug prices in the United States: Reasons and proposedsolutions.Journalof Oncology Practice,10(4),e208-e211. DOI:&nbsp10.1200/JOP.2013.001351